LRI Investments’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$642K Buy
6,998
+30
+0.4% +$2.63K 0.05% 166
2026
Q1
$594K Buy
6,968
+2,578
+59% +$230K 0.05% 162
2025
Q4
$347K Sell
4,390
-1,254
-22% -$98.3K 0.03% 210
2025
Q3
$451K Hold
5,644
0.04% 188
2025
Q2
$513K Hold
5,644
0.04% 176
2025
Q1
$529K Buy
5,644
+207
+4% +$18.5K 0.05% 160
2024
Q4
$494K Hold
5,437
0.05% 139
2024
Q3
$497K Buy
5,437
+2,337
+75% +$238K 0.05% 149
2024
Q2
$301K Buy
3,100
+166
+6% +$15.3K 0.03% 184
2024
Q1
$264K Buy
+2,934
New +$249K 0.07% 119

Other funds holding CL

LRI Investments's CL Position: Q2 2026 in Review

LRI Investments increased its Colgate-Palmolive (CL) stake by 0.43% in Q2 2026, buying an estimated $2.63K and bringing the position to 6,998 shares worth $642K. The position accounts for 0.05% of the portfolio, ranked #166.

LRI Investments first reported a position in CL in Q1 2024 and has held it in 10 quarters since. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • LRI Investments held 6,998 shares of Colgate-Palmolive worth $642K as of Q2 2026.
  • LRI Investments bought 30 Colgate-Palmolive shares in Q2 2026, an estimated $2.63K.
  • Colgate-Palmolive made up 0.05% of LRI Investments's portfolio in Q2 2026, its #166 holding.
  • LRI Investments first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 10 quarters since.
  • 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.